ATIMIAC 20 mg/5 mg per ml, eye drop solution bottle, 10 ml
Active ingredients: Dorzolamide hydrochloride, Dorzolamide, Timolol maleate, TIMOLOL
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 10 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATIMIAC 20 mg/5 mg par mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon polyéthylène basse densité (PEBD) avec fermeture à témoin d'effraction de 10 mL
- Marketing authorisation holder
- HORUS PHARMA
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62005381CIP73033321CIP133400930333211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | — | SA |
| TIMOLOLcollyre | 5 mg · un 1 mL de collyre | FT |
| DORZOLAMIDEcollyre | 20 mg · un 1 mL de collyre | FT |
| CHLORHYDRATE DE DORZOLAMIDEcollyre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.